Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2015).
Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence.
Articles are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Sci. Pharm. 2009, 77(Short Lectures (SL)), 180; https://doi.org/10.3797/scipharm.oephg.21.SL-13 (registering DOI)
Validation of Fluorimetric Assay of Histone Deacetylase for Inhibitors from Plant Origin
Department of Pharmacognosy, University Vienna, Althanstraße 14, 1090, Vienna, Austria
Author to whom correspondence should be addressed.
Received: 16 April 2009 / Accepted: 16 April 2009 / Published: 16 April 2009
Abstract Histone deacetylase inhibitors (HDACi) have received high interest as anti-cancer agents recently. HDACi may influence tumor growth by an inhibition of angiogenesis as well as by increasing tumor cell immunogenicity . In many clinical trials the effect of several HDACi on different tumors are studied at the moment .
This is an open access article distributed under the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
Share & Cite This Article
MDPI and ACS Style
KRASTEVA, S.M.; KRENN, L. Validation of Fluorimetric Assay of Histone Deacetylase for Inhibitors from Plant Origin. Sci. Pharm. 2009, 77, 180.
KRASTEVA SM, KRENN L. Validation of Fluorimetric Assay of Histone Deacetylase for Inhibitors from Plant Origin. Scientia Pharmaceutica. 2009; 77(Short Lectures (SL)):180.
KRASTEVA, S. M.; KRENN, L. 2009. "Validation of Fluorimetric Assay of Histone Deacetylase for Inhibitors from Plant Origin." Sci. Pharm. 77, Short Lectures (SL): 180.
Show more citation formats
Show less citations formats
[Return to top]
For more information on the journal statistics, click here
Multiple requests from the same IP address are counted as one view.